Tucatinib and Trastuzumab for Previously Treated Human Epidermal Growth Factor Receptor 2–Positive Metastatic Biliary Tract Cancer (SGNTUC-019): A Phase II Basket StudyYoshiaki Nakamura, Tanios Bekaii‐Saab, Seung Tae Kim et al.|Journal of Clinical Oncology|2023Cited by 100
Quality of life among Korean gastrointestinal cancer survivorsSoojung Ahn, Sang Hui Chu, Hyejeong Jung et al.|European Journal of Oncology Nursing|2017Cited by 26
Inhibition of IRP2-dependent reprogramming of iron metabolism suppresses tumor growth in colorectal cancerJieon Hwang, Sang Joon Shin|Cell Communication and Signaling|2024Cited by 16
Oxaliplatin-induced Peripheral Neuropathy, Symptoms, Distress and Quality of Life among Korean Patients with Gastrointestinal CancerHye Jeong Jung, Sang Hui Chu, Yoo Ri Yang et al.|Asian Oncology Nursing|2019Cited by 1